ProfileGDS5822 / ILMN_2947559
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 97% 97% 98% 94% 96% 98% 95% 98% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 12061.497
GSM1276600PDAC Late Ablation Control 21666.997
GSM1276601PDAC Late Ablation Control 32621.498
GSM1276602PDAC Late Ablation 1909.394
GSM1276603PDAC Late Ablation 21480.496
GSM1276604PDAC Late Ablation 34106.998
GSM1303940PDAC Late Ablation_anti-CTLA4 11263.295
GSM1303941PDAC Late Ablation_anti-CTLA4 22605.798
GSM1303942PDAC Late Ablation_anti-CTLA4 32989.298